Blog
RSS FeedPosted by Michael Wonder on 21 Apr 2020
The controversial malaria drug has been approved for an official trial
21 April 2020 - A massive new clinical trial has begun in Australia to test if an HIV or a ...
Posted by Michael Wonder on 20 Apr 2020
COVID-19 treatment remedsivir is not available for Australian trial
20 April 2020 - A landmark Australian COVID-19 trial will not get to test the most promising therapy, as it can ...
Posted by Michael Wonder on 20 Apr 2020
Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalised COVID-19 patients
20 April 2020 - Novartis has reached an agreement with the US FDA to proceed with a Phase III clinical trial ...
Posted by Michael Wonder on 18 Apr 2020
Finding effective treatments for COVID-19: scientific integrity and public confidence in a time of crisis
16 April 2020 - Everyone wants new treatments and vaccines to address the devastation of coronavirus disease 2019 (COVID-19). ...
Posted by Michael Wonder on 16 Apr 2020
EMA shares advice on validated computer systems used in clinical trials
16 April 2020 - The EMA has published a notice about validating and qualifying all types of computerised systems used ...
Posted by Michael Wonder on 16 Apr 2020
A strategy for improving U.S. health care delivery — conducting more randomised, controlled trials
16 April 2020 - Despite the prominence of randomised, controlled trials in medical research, they have rarely been used to evaluate ...
Posted by Michael Wonder on 14 Apr 2020
Why a decades old TB vaccine is getting attention in the fight against COVID-19
14 April 2020 - In the desperate search for ammunition to fend off the COVID-19 pandemic, a decades old tuberculosis ...
Posted by Michael Wonder on 09 Apr 2020
Global regulators stress need for robust evidence on COVID-19 treatments
9 April 2020 - International regulators have published a report today highlighting their considerations on the development of potential COVID-19 ...
Posted by Michael Wonder on 02 Apr 2020
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK
2 April 2020 - The pair of phase 3 trials will take place across 15 clinical sites in the UK. ...
Posted by Michael Wonder on 31 Mar 2020
Clinical trial processes
31 March 2020 - The TGA has received a number of enquiries about processes for clinical trials relating to COVID-19 ...
Posted by Michael Wonder on 30 Mar 2020
FDA guidance on conduct of clinical trials of medical products during the COVID-19 pandemic
30 March 2020 - The U.S. FDA today issued an updated guidance, “Conduct of Clinical Trials of Medical Products during ...
Posted by Michael Wonder on 26 Mar 2020
COVID-19: frontline virus fighters to trial TB vaccine
27 March 2020 - Thousands of Australian doctors, nurses and health workers will be given a tuberculosis vaccine in a ...
Posted by Michael Wonder on 26 Mar 2020
Preserving clinical trial integrity during the coronavirus pandemic
25 March 2020 - Randomised clinical trials provide the highest-quality evidence for identifying therapies to help people attain longer and healthier ...
Posted by Michael Wonder on 25 Mar 2020
COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?
24 March 2020 - Coronavirus disease 2019 is a current pandemic infection caused by a positive-sense RNA virus named the severe ...
Posted by Michael Wonder on 25 Mar 2020
Treating COVID-19—off-label drug use, compassionate use, and randomised clinical trials during pandemics
24 March 2020 - In the 2014 Ebola outbreak, close to 30 000 individuals developed Ebola viral disease, and numerous therapies were ...